Targeting breast and pancreatic cancer metastasis using a dual-cadherin antibody

The successful application of antibody-based therapeutics in either primary or metastatic cancer depends upon the selection of rare cell surface epitopes that distinguish cancer cells from surrounding normal epithelial cells. By contrast, as circulating tumor cells (CTCs) transit through the bloodst...

Descripción completa

Detalles Bibliográficos
Autores principales: Micalizzi, Douglas S., Che, Dante, Nicholson, Benjamin T., Edd, Jon F., Desai, Niyati, Lang, Evan R., Toner, Mehmet, Maheswaran, Shyamala, Ting, David T., Haber, Daniel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618049/
https://www.ncbi.nlm.nih.gov/pubmed/36256815
http://dx.doi.org/10.1073/pnas.2209563119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618049/
https://www.ncbi.nlm.nih.gov/pubmed/36256815
http://dx.doi.org/10.1073/pnas.2209563119

Ejemplares similares